Dr Coates is Associate Professor, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom and is a National Institute for Health Research Clinician Scientist. Her research focuses on optimal therapeutic strategies in psoriatic arthritis (PsA). Dr Coates completed her rheumatology training and PhD at the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom. Her PhD focused on the development of the minimal disease activity criteria for PsA and establishment of the Tight Control of Inflammation in Early Psoriatic Arthritis (TICOPA) trial, the first study to show the benefit of treating to target in PsA. Her research is clinical and focuses on PsA and the spondyloarthritides, including early diagnosis of PsA, development of PsA-specific and validated outcome measures, optimal treatment pathways and strategies in PsA.

Dr Coates was awarded one of eight UK Scopus Young Researcher Awards in 2011 and a University of Leeds Women of Achievement Award in 2012. She is a member of the steering committee of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and the British Psoriatic Arthritis Consortium. Dr Coates was first author on the 2015 GRAPPA treatment recommendations for psoriasis and PsA and is also involved in the GRAPPA–Outcome Measures in Rheumatology (OMERACT) initiative to refine the core set of outcome measures for PsA.